Financials Healthcare Integrated Technologies, Inc.
Equities
TCKF
US4220091007
Electronic Equipment & Parts
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 USD | +6.19% | -2.44% | +49.07% |
Valuation
Fiscal Period: July | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 21.05 | 6.498 | 14.59 | 16.01 | 3.376 | 4.337 |
Enterprise Value (EV) 1 | 21.84 | 7.456 | 15.43 | 16.75 | 4.424 | 5.263 |
P/E ratio | -8.79 x | -7.75 x | -13.6 x | -10.3 x | -2.47 x | -3 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - |
EV / EBITDA | -11.2 x | -9.63 x | -15.3 x | -13.2 x | -3.93 x | -5.57 x |
EV / FCF | 92.6 x | 50.1 x | 102 x | 71.7 x | 9.51 x | -2.89 x |
FCF Yield | 1.08% | 2% | 0.98% | 1.4% | 10.5% | -34.6% |
Price to Book | -14.7 x | -3.67 x | -8.51 x | -9.07 x | -1.39 x | -9.19 x |
Nbr of stocks (in thousands) | 32,488 | 32,488 | 33,938 | 40,018 | 42,205 | 48,194 |
Reference price 2 | 0.6480 | 0.2000 | 0.4300 | 0.4000 | 0.0800 | 0.0900 |
Announcement Date | 20/03/20 | 20/03/20 | 16/10/20 | 28/10/21 | 23/09/22 | 13/11/23 |
Income Statement Evolution (Annual data)
Fiscal Period: July | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales | - | - | - | - | - | - |
EBITDA 1 | -1.948 | -0.7744 | -1.011 | -1.266 | -1.127 | -0.9447 |
EBIT 1 | -1.952 | -0.784 | -1.016 | -1.275 | -1.138 | -0.9616 |
Operating Margin | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -1.966 | -0.8229 | -1.057 | -1.455 | -1.361 | -1.302 |
Net income 1 | -2.051 | -0.8385 | -1.058 | -1.455 | -1.361 | -1.302 |
Net margin | - | - | - | - | - | - |
EPS 2 | -0.0737 | -0.0258 | -0.0317 | -0.0389 | -0.0324 | -0.0300 |
Free Cash Flow 1 | 0.2358 | 0.1489 | 0.1509 | 0.2337 | 0.4651 | -1.821 |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 20/03/20 | 20/03/20 | 16/10/20 | 28/10/21 | 23/09/22 | 13/11/23 |
Balance Sheet Analysis
Fiscal Period: July | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 0.78 | 0.96 | 0.84 | 0.75 | 1.05 | 0.93 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | -0.4022 x | -1.238 x | -0.8263 x | -0.5891 x | -0.9294 x | -0.9797 x |
Free Cash Flow 1 | 0.24 | 0.15 | 0.15 | 0.23 | 0.47 | -1.82 |
ROE (net income / shareholders' equity) | 207% | 54.9% | 58.5% | 80.6% | 64.9% | 84.2% |
ROA (Net income/ Total Assets) | -936% | -428% | -703% | -245% | -117% | -73.7% |
Assets 1 | 0.2191 | 0.1961 | 0.1504 | 0.595 | 1.164 | 1.766 |
Book Value Per Share 2 | -0.0400 | -0.0500 | -0.0500 | -0.0400 | -0.0600 | -0.0100 |
Cash Flow per Share 2 | 0.0100 | 0 | 0 | 0 | 0 | 0 |
Capex 1 | 0 | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 20/03/20 | 20/03/20 | 16/10/20 | 28/10/21 | 23/09/22 | 13/11/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+49.07% | 8.82M | |
+31.79% | 78.46B | |
+69.86% | 75.85B | |
+1.84% | 36.57B | |
-6.53% | 31.9B | |
-10.61% | 13.73B | |
-5.13% | 10.82B | |
+18.48% | 10.66B | |
-2.87% | 10.25B | |
+51.34% | 10.04B |
- Stock Market
- Equities
- TCKF Stock
- Financials Healthcare Integrated Technologies, Inc.